Compounds > ribavirin

Page last updated: 2024-08-16

ribavirin and Myasthenia Gravis

ribavirin has been researched along with Myasthenia Gravis in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (62.50)	29.6817
2010's	3 (37.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Congeni, JP; Kirkpatrick, RB	1
Saleem, A	1
Baik, SJ; Kim, HI; Kim, TH; Rhie, JY	1
Hwang, JM; Jeong, SH; Kang, HM; Kim, JW; Park, MJ	1
Evoli, A; Servidei, S	1
Altan, M; Bektas, H; Bektas, M; Cetinkaya, H; Gören, D	1
Casassus-Buihle, D; Chauveau, E; Fraudin, A; Oddes, B; Reffet, A; Terrier, F	1
Chamuleau, RA; Molenaar, DS; Reesink, HW; Weegink, CJ	1

Other Studies

8 other study(ies) available for ribavirin and Myasthenia Gravis

Article	Year
Pegylated interferon induced myasthenia crisis--a case report. Journal of clinical neuromuscular disease, 2013, Volume: 14, Issue:3 Topics: Hepatitis C; Humans; Immunoglobulins, Intravenous; Interferon-alpha; Male; Middle Aged; Myasthenia Gravis; Polyethylene Glycols; Ribavirin; Treatment Outcome	2013
Unmasking of myasthenia gravis during pegylated Alfa 2 a interferon and ribavirin therapy for chronic hepatitis C. JPMA. The Journal of the Pakistan Medical Association, 2016, Volume: 66, Issue:5 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Myasthenia Gravis; Ribavirin	2016
Myasthenia Crisis Induced by Pegylated-Interferon in Patient With Chronic Hepatitis C: A Case Report. Medicine, 2016, Volume: 95, Issue:21 Topics: Adrenal Cortex Hormones; Antiviral Agents; Cholinesterase Inhibitors; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Myasthenia Gravis; Polyethylene Glycols; Respiration, Artificial; Ribavirin; Thymoma; Thymus Neoplasms	2016
Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C. The Korean journal of hepatology, 2009, Volume: 15, Issue:2 Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Myasthenia Gravis; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2009
Peginterferon and ribavirin for hepatitis C. The New England journal of medicine, 2007, Mar-22, Volume: 356, Issue:12 Topics: Adult; Antiviral Agents; Autoimmune Diseases; Contraindications; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Myasthenia Gravis; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2007
Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin. Digestion, 2007, Volume: 75, Issue:4 Topics: Antiviral Agents; Diagnosis, Differential; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Middle Aged; Myasthenia Gravis; Ribavirin	2007
[Development of a myasthenia crisis during interferon treatment for chronic C hepatitis]. Gastroenterologie clinique et biologique, 2007, Volume: 31, Issue:12 Topics: Aged; Antiviral Agents; Cholinesterase Inhibitors; Follow-Up Studies; Glucocorticoids; Hepatitis C, Chronic; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Male; Myasthenia Gravis; Mycophenolic Acid; Prednisone; Pyridostigmine Bromide; Ribavirin	2007
Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin. Journal of gastroenterology, 2001, Volume: 36, Issue:10 Topics: Adult; Antiviral Agents; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Myasthenia Gravis; Ribavirin	2001